# Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma

> **NCT00625352** · PHASE2 · UNKNOWN · sponsor: **Ulsan University Hospital** · enrollment: 48 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Gemcitabine, UFT

## Key facts

- **NCT ID:** NCT00625352
- **Lead sponsor:** Ulsan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2008-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00625352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00625352, "Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00625352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*